Skip to main content
. 2024 Oct 22;25(21):11366. doi: 10.3390/ijms252111366

Figure 3.

Figure 3

PhAs-LHP inhibited pancreatic cancer cell growth more potently. Human (MiaPaCa-2 (A) and PANC-1 (B)) and murine TB33117 (C) pancreatic cancer (PC) cells were incubated with ATO, PhAs-LHP, or the peptide LHP for 48 h. Cell proliferation was measured by the MTT assay. The values of control cells without any treatment were defined as 100%. The results were summarized from at least three independent experiments.